-
Bufuralol Hydrochloride: Expanding Applications in Human ...
2025-09-22
This article explores the innovative use of Bufuralol hydrochloride, a non-selective β-adrenergic receptor antagonist, in human intestinal organoid models for cardiovascular pharmacology research. Emphasizing β-adrenergic modulation studies and practical guidance for experimental design, it highlights new directions for integrating pharmacokinetics and disease modeling.
-
Tilbroquinol
2025-09-19
-
Vardenafil HCl Trihydrate: Precision Tools for Proteoform...
2025-09-19
Explore the application of Vardenafil HCl Trihydrate, a potent and selective PDE5 inhibitor, in advanced smooth muscle relaxation research and proteoform-specific signaling studies. This article highlights novel strategies for integrating Vardenafil into cGMP pathway investigations and vascular models.
-
VU0424465
2025-09-19
-
Berberine (CAS 2086-83-1): Modulating Inflammation and Me...
2025-09-18
Explore the multifaceted applications of Berberine (CAS 2086-83-1), an isoquinoline alkaloid and AMPK activator for metabolic regulation, in inflammation, lipid metabolism, and metabolic disease research. This review highlights recent mechanistic insights, including LDL receptor upregulation and crosstalk with inflammasome pathways, and offers technical guidance for experimental setups.
-
Anti-Phospho-MCM2 (Ser41) Rabbit Monoclonal Antibody
2025-09-18
-
Anti-PIAS1 Rabbit Monoclonal Antibody
2025-09-18
-
Anti-COPS8 Rabbit Monoclonal Antibody
2025-09-17
-
Anti-TEM1EndosialinCD248 Antibody (Ontuxizumab)
2025-09-17
-
Polyphyllin D
2025-09-16
-
Amlodipine maleate
2025-09-15
-
Monoacetylphloroglucinol
2025-09-13
-
Nicotinamide
2025-09-13
-
Fmoc-p-amino-benzoic acid,Fmoc-4-Abz-OH
2025-09-12
-
Anti-Glutamate Receptor 1 Rabbit Monoclonal Antibody
2025-09-11